---
id: culture-negative-endocarditis_081
category: clinical_syndromes
tags: [culture-negative-endocarditis, Coxiella-burnetii, Bartonella, Tropheryma-whipplei, Q-fever, serologies]
deck: Infectious Diseases
created: 2025-11-10
modified: 2025-11-10
---

## Culture-Negative Endocarditis

**Q:** What are the causes, diagnostic approach, and treatment strategies for culture-negative infective endocarditis?

**A:**

**Definition:**
- **Culture-Negative Endocarditis (CNE):** IE with negative routine blood cultures despite ≥3 sets obtained before antibiotics
- **Incidence:** 5-31% of all IE cases (varies by region, prior antibiotics)

---

## CAUSES OF CULTURE-NEGATIVE ENDOCARDITIS

---

### **1. Prior Antibiotic Therapy (#1 CAUSE - 40-60%)**

**Mechanism:**
- **Suppresses bacterial growth** in blood cultures
- Does NOT sterilize vegetations (bacteria still present but non-culturable)

**Risk Factors:**
- **Antibiotics within 2 weeks** prior to blood cultures
- **Even a single dose** can suppress growth

**Diagnosis:**
- **Clinical Duke criteria** (fever, vegetation on echo, emboli)
- **Consider empiric treatment** based on epidemiology

**Key Point:** **#1 cause of CNE = prior antibiotics** (40-60%)

---

### **2. Fastidious Organisms**

**Organisms Difficult to Culture:**

---

#### **A. *Coxiella burnetii* (Q Fever) - 3-11% of CNE**

**Epidemiology:**
- **Worldwide** (endemic in Mediterranean, Middle East, Australia)
- **Exposure:** Farm animals (cattle, sheep, goats), raw milk, parturient animals
- **Chronic Q fever = endocarditis** (acute Q fever = pneumonia, hepatitis)

**Clinical Features:**
- **Prosthetic valves or pre-existing valve disease** (70-80% of cases)
- **Indolent course** (months to years)
- **Fever** (may be low-grade or absent)
- **Heart failure**
- **Extracardiac manifestations:** Hepatosplenomegaly, glomerulonephritis, purpuric rash

**Diagnosis:**
- **Serology (GOLD STANDARD):**
  - **IgG phase I antibody titer ≥1:800** = diagnostic (Duke major criterion)
  - IgG phase II usually elevated too (but phase I > phase II = chronic infection)
- **PCR:** From valve tissue (if surgery)
- **Blood cultures:** Negative (Coxiella is obligate intracellular)

**Treatment:**
- **Doxycycline** 100 mg PO BID + **Hydroxychloroquine** 200 mg PO TID
- **Duration:** **≥18 months** (minimum, often 2-3 years)
- **Monitor IgG phase I titer** (goal <1:200)
- **Hydroxychloroquine alkalinizes phagolysosomes** → Enhances doxycycline activity

**Key Point:** **Q fever endocarditis = doxycycline + hydroxychloroquine x ≥18 months**

---

#### **B. *Bartonella* species - 3-5% of CNE**

**Species:**
- ***Bartonella henselae*** (cat-scratch disease)
- ***Bartonella quintana*** (trench fever, homeless/body lice)

**Epidemiology:**
- **Cat exposure** (B. henselae - flea vector, cat scratch/bite)
- **Homelessness, poor hygiene** (B. quintana - body lice)

**Clinical Features:**
- **Prosthetic valves or pre-existing valve disease**
- **Fever, emboli**
- **Extracardiac:** Lymphadenopathy (cat-scratch), cutaneous lesions, hepatosplenomegaly

**Diagnosis:**
- **Serology (First-Line):**
  - **IgG antibody titer ≥1:800** (cross-reacts between species)
  - Positive in 90-95%
- **PCR:** From blood or valve tissue (more sensitive than serology)
- **Culture:** Possible but requires **prolonged incubation (2-6 weeks)** on specialized media (not routine)

**Treatment:**
- **Doxycycline** 100 mg IV/PO BID x **6 weeks**
  **PLUS**
- **Gentamicin** 3 mg/kg IV q24h x **2 weeks** (first 2 weeks)

**Alternative (PCN Allergy):**
- **Doxycycline** + **Rifampin** 300 mg PO BID x 6 weeks

**Key Point:** **Bartonella = cat exposure or homelessness + doxycycline + gentamicin**

---

#### **C. *Tropheryma whipplei* (Whipple Disease) - <1% of CNE**

**Epidemiology:**
- **Rare** (middle-aged white men, farmers)
- **Systemic Whipple disease:** GI symptoms (diarrhea, malabsorption, weight loss), arthralgia, CNS symptoms

**Clinical Features:**
- **Endocarditis without systemic Whipple** (rare)
- **Often prosthetic valves**
- **Indolent course**

**Diagnosis:**
- **PCR:** From blood, valve tissue, duodenal biopsy (GOLD STANDARD)
- **Duodenal biopsy:** PAS-positive macrophages (if systemic Whipple)
- **Culture:** Not routinely available

**Treatment:**
- **Ceftriaxone** 2g IV q24h OR **Penicillin G** 2 million units IV q4h x **2 weeks**
  **THEN**
- **TMP-SMX** DS 1 tab PO BID x **1 year**

**Alternative:**
- **Doxycycline** 200 mg PO daily + **Hydroxychloroquine** 200 mg PO TID x 1 year

**Key Point:** **Whipple endocarditis = ceftriaxone x 2 weeks → TMP-SMX x 1 year**

---

#### **D. *Mycoplasma hominis* (Prosthetic Valve Endocarditis)**

**Epidemiology:**
- **Prosthetic valve endocarditis** (rare)
- **Genital tract flora**

**Diagnosis:**
- **PCR** (blood, valve tissue)
- **Culture:** Requires specialized media

**Treatment:**
- **Doxycycline** 100 mg IV/PO BID OR **Fluoroquinolone** (levofloxacin, moxifloxacin)
- **Duration:** ≥6 weeks

---

#### **E. HACEK Organisms (Historically, Now Detected in 5-7 Days)**

**Organisms:** *Haemophilus*, *Aggregatibacter*, *Cardiobacterium*, *Eikenella*, *Kingella*

**Modern Era:**
- **Automated blood culture systems detect within 5-7 days**
- **No longer truly "culture-negative"**

**Treatment:**
- **Ceftriaxone** 2g IV q24h x 4-6 weeks

---

#### **F. Legionella, Chlamydia, Brucella (VERY RARE)**

**Diagnosis:**
- **Serology, PCR**

**Treatment:**
- **Fluoroquinolone** or **Doxycycline** (organism-specific)

---

### **3. Fungal Endocarditis**

**Organisms:**
- ***Candida* species** (*C. albicans*, *C. parapsilosis*, *C. tropicalis*)
- ***Aspergillus* species**
- **Other molds** (Histoplasma, Coccidioides - very rare)

**Risk Factors:**
- **Prosthetic valves**
- **IV drug use**
- **Immunosuppression**
- **Prior broad-spectrum antibiotics**

**Diagnosis:**
- **Blood cultures:** May be positive for Candida (but often negative for Aspergillus)
- **Serology:** β-D-glucan (elevated in Candida, Aspergillus)
- **Valve tissue:** Histopathology, culture

**Treatment:**
- **Amphotericin B** 0.7-1 mg/kg IV q24h OR **Echinocandin** (caspofungin, micafungin)
- **Surgery ALMOST ALWAYS required** (medical therapy alone fails)

**Key Point:** **Fungal endocarditis = very high mortality (50-80%)** without surgery

---

### **4. Non-Infectious Endocarditis**

**A. Marantic (Non-Bacterial Thrombotic) Endocarditis:**
- **Sterile vegetations** (platelets + fibrin)
- **Associated with malignancy** (adenocarcinoma, especially pancreatic, gastric, lung)
- **Hypercoagulable state**
- **No fever, negative cultures**

**Diagnosis:**
- **TEE:** Vegetations (usually small, <5 mm)
- **Negative blood cultures**
- **Search for underlying malignancy**

**Treatment:**
- **Anticoagulation** (heparin, warfarin)
- **Treat underlying cancer**

---

**B. Libman-Sacks Endocarditis:**
- **Sterile vegetations** in **systemic lupus erythematosus (SLE)**
- **Antiphospholipid antibody syndrome (APLS)**
- **No fever, negative cultures**

**Diagnosis:**
- **TEE:** Vegetations (usually mitral or aortic valve)
- **Positive ANA, anti-dsDNA, anticardiolipin antibodies**

**Treatment:**
- **Treat underlying SLE**
- **Anticoagulation** if APLS

---

## DIAGNOSTIC APPROACH TO CULTURE-NEGATIVE ENDOCARDITIS

---

**Step 1: Confirm Endocarditis (Duke Criteria)**
- **Echocardiography:** TTE → TEE (if TTE negative)
- **Clinical features:** Fever, new murmur, emboli, immunologic/vascular phenomena

---

**Step 2: Review Antibiotic History**
- **Prior antibiotics within 2 weeks?**
- If yes → **Treat empirically** based on epidemiology (see below)

---

**Step 3: Serologies for Fastidious Organisms**

**Order:**
- ***Coxiella burnetii* (Q fever):** IgG phase I antibody (≥1:800 diagnostic)
- ***Bartonella* species:** IgG antibody (≥1:800)
- ***Brucella* species:** Serology (if endemic area or exposure)
- ***Mycoplasma hominis*:** PCR (if prosthetic valve)
- ***Legionella*:** Urinary antigen (if pneumonia + IE)

**Key Point:** **Always check *Coxiella* and *Bartonella* serologies** in CNE

---

**Step 4: Molecular Diagnostics**

**PCR (If Available):**
- **16S/18S rRNA gene sequencing** from blood or valve tissue
- **Pathogen-specific PCR** (*Bartonella*, *Tropheryma*, *Mycoplasma*, *Coxiella*)

---

**Step 5: Histopathology & Culture of Valve Tissue (If Surgery)**

**Valve Excision:**
- **Send for:**
  - **Routine bacterial culture** (including prolonged incubation)
  - **Fungal culture**
  - **Mycobacterial culture** (if chronic IE)
  - **Histopathology** (Gram stain, PAS stain, GMS stain for fungi)
  - **PCR** (broad-range, pathogen-specific)

---

**Step 6: Fungal Workup (If High Risk)**

**β-D-Glucan:**
- Elevated in Candida, Aspergillus (but not specific)

**Candida PCR:**
- From blood (if available)

---

**Step 7: Consider Non-Infectious Causes**

**Marantic Endocarditis:**
- Search for **malignancy** (CT chest/abdomen/pelvis)
- Check **hypercoagulable workup**

**Libman-Sacks (SLE):**
- **ANA, anti-dsDNA, complement (C3, C4)**
- **Anticardiolipin, lupus anticoagulant**

---

## EMPIRIC TREATMENT OF CULTURE-NEGATIVE ENDOCARDITIS

**Key Principle:** **Treat based on epidemiology and risk factors** (prior antibiotics vs. fastidious organisms)

---

### **Empiric Regimen (Community-Acquired, Native Valve):**

**Coverage:** Viridans strep, HACEK, *Bartonella*

| **Agent** | **Dosing** | **Duration** |
|-----------|------------|--------------|
| **Ampicillin-sulbactam** | 3g IV q6h | 4-6 weeks |
| **PLUS** | | |
| **Gentamicin** | 3 mg/kg IV q24h | 2 weeks |

**Rationale:**
- **Ampicillin-sulbactam:** Viridans strep, HACEK
- **Gentamicin:** Synergy for streptococci, covers *Bartonella*

---

### **Empiric Regimen (Healthcare-Associated, Prosthetic Valve, or IVDU):**

**Coverage:** MRSA, CoNS, Gram-negatives, *Candida* (consider)

| **Agent** | **Dosing** | **Duration** |
|-----------|------------|--------------|
| **Vancomycin** | 15 mg/kg IV q12h | 6 weeks |
| **PLUS** | | |
| **Gentamicin** | 3 mg/kg IV q24h | 2 weeks |
| **PLUS** | | |
| **Cefepime** OR **Ceftazidime** | 2g IV q8h | 6 weeks |
| **PLUS (if high fungal risk)** | | |
| **Caspofungin** OR **Micafungin** | 70 mg IV x1, then 50 mg IV q24h | Until fungal IE excluded |

---

### **Pathogen-Specific Treatment (If Identified):**

| **Organism** | **Regimen** | **Duration** |
|--------------|-------------|--------------|
| ***Coxiella burnetii*** (Q fever) | **Doxycycline** 100 mg PO BID + **Hydroxychloroquine** 200 mg PO TID | **≥18 months** |
| ***Bartonella*** | **Doxycycline** 100 mg IV/PO BID + **Gentamicin** 3 mg/kg IV q24h (x2 weeks) | **6 weeks** |
| ***Tropheryma whipplei*** | **Ceftriaxone** 2g IV q24h x 2 weeks → **TMP-SMX** DS PO BID | **1 year** |
| ***Mycoplasma hominis*** | **Doxycycline** 100 mg IV/PO BID | **≥6 weeks** |
| **HACEK** | **Ceftriaxone** 2g IV q24h | **4-6 weeks** |
| **Fungal (Candida)** | **Amphotericin B** OR **Echinocandin** + **Surgery** | **≥6 weeks** |

---

## SURGICAL INDICATIONS (SAME AS CULTURE-POSITIVE IE)

**Class I Indications:**
- **Heart failure** (severe valve dysfunction)
- **Uncontrolled infection** (persistent fever/bacteremia despite antibiotics)
- **Perivalvular abscess**
- **Large vegetation >10 mm** + embolic event
- **Fungal endocarditis** (almost always requires surgery)

---

## OUTCOMES & PROGNOSIS

**Prognosis:**
- **Similar to culture-positive IE** (if appropriate treatment)
- **Delayed diagnosis → ↑ mortality** (especially if fungal)

**Predictors of Poor Outcome:**
- **Fungal endocarditis** (50-80% mortality)
- **Prosthetic valve IE**
- **Heart failure**
- **CNS complications**

---

**Mnemonic: "Q-BAT for Culture-Negative IE"**
- **Q** = *Coxiella burnetii* (Q fever)
- **B** = *Bartonella* (cat-scratch, homelessness)
- **A** = Prior **A**ntibiotics (#1 cause)
- **T** = *Tropheryma whipplei* (Whipple disease)

**Mnemonic: "Q Fever = Doxy + Hydroxy for 18+"**
- **Q** fever = *Coxiella burnetii*
- **Doxy** = Doxycycline
- **Hydroxy** = Hydroxychloroquine
- **18+** = ≥18 months

**Mnemonic: "Bartonella = Cats + Doxy + Gent"**
- **B**artonella henselae = **C**ats
- **D**oxycycline
- **G**entamicin

**Clinical Pearls:**
- **#1 cause of CNE = prior antibiotics** (40-60%)
- **Always check *Coxiella* and *Bartonella* serologies** in CNE
- ***Coxiella burnetii* (Q fever):** IgG phase I ≥1:800 = diagnostic (Duke major criterion)
- **Q fever endocarditis:** Doxycycline + hydroxychloroquine x ≥18 months (monitor IgG titer)
- ***Bartonella*:** Cat exposure or homelessness → Doxycycline + gentamicin x 6 weeks
- ***Tropheryma whipplei* (Whipple):** Ceftriaxone x 2 weeks → TMP-SMX x 1 year
- **HACEK no longer "culture-negative"** (detected in 5-7 days with modern systems)
- **Fungal IE almost always requires surgery** (medical therapy alone fails)
- **Empiric CNE treatment:** Ampicillin-sulbactam + gentamicin (community) OR vancomycin + gentamicin + cefepime (healthcare)
- **Valve tissue PCR** (16S rRNA sequencing) can identify fastidious organisms
- **Non-infectious causes:** Marantic endocarditis (cancer), Libman-Sacks (SLE)
- **CNE = 5-31% of all IE** (varies by prior antibiotics, region)

**Media:** None

**Sources:** [IDSA 2015 - Infective Endocarditis Guidelines], [PMC 2024 - Culture-negative endocarditis review], [European Heart Journal 2023 - Q fever endocarditis], [Clinical Microbiology Reviews 2024 - Bartonella endocarditis], [JAMA 2023 - Diagnostic approach to CNE], [AHA 2021 - Fastidious organisms in IE]
